Dr. Raza is an Assistant Professor of Clinical Medicine at Medicine at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital/ Columbia University Medical Center in Manhattan. After obtaining his medical degree from Dow Medical College, Karachi, Pakistan, he received his internal Medicine training from Dow University of Health Sciences, Karachi, Pakistan. In 2007, Dr. Raza moved to the United States and joined New York University School of Medicine and performed his research on "anti-angiogenic therapies" under the mentorship of Michael L. Gruber MD and Silvia Formenti MD. His published work on anti-angiogenic therapies was widely recognized and presented in multiple peer reviewed conferences including American Society of Clinical Oncology. Dr. Raza did his medical residency and chief residency at Brookdale University Medical Center, New York and fellowship in Hematology & Oncology and chief fellowship in Hematology & Oncology at Ellis Fischel Cancer Center, University of Missouri Columbia. He also worked as visiting fellow in Stem cell transplant unit at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University at St. Louis. Dr. Raza has published over 60 research articles editorials, chapters in the field of medical oncology and hematology. His manuscripts have been widely cited in top recognized medical journals including New England Journal of Medicine. Dr. Raza is also an external reviewer for various medical journals. Due to his significant contribution to research and patient care, Dr. Raza was recognized as "Outstanding fellow" by the State of Missouri. He was also awarded as "First Michael Perry Fellow Award" by the University of Missouri. Recently, Dr. Raza was elected as Fellow of American College of Physician, a distinction earned from colleagues recognize accomplishments and achievements over and above the practice of medicine. Dr. Raza has joined Multiple Myeloma/Amyloidosis program at Columbia University and provide treatment for patients with plasma cell dyscrasia including MGUS, multiple myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, and POEM syndrome. Dr. Raza is currently conducting various clinical trials on multiple Myeloma and Amyloidosis at Columbia University Medical Center. His main focus is to identify the novel treatments in the management of plasma cell neoplasm.
Looking for a Hematology Specialist? We found others matching your search, to help you compare.